ETOMIDATE

N/A

Manufactured by Hospira, Inc.

5,192 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ETOMIDATE

ETOMIDATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Hospira, Inc.. The most commonly reported adverse reactions for ETOMIDATE include RENAL FAILURE, PAIN, INJURY, ANXIETY, UNEVALUABLE EVENT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ETOMIDATE.

Top Adverse Reactions

RENAL FAILURE238 reports
PAIN204 reports
INJURY186 reports
ANXIETY180 reports
UNEVALUABLE EVENT168 reports
DRUG INEFFECTIVE159 reports
FEAR154 reports
HYPOTENSION150 reports
EMOTIONAL DISTRESS144 reports
CARDIAC ARREST143 reports
RENAL INJURY134 reports
RENAL IMPAIRMENT123 reports
DEATH121 reports
STRESS116 reports
ANHEDONIA112 reports
MULTI ORGAN FAILURE107 reports
DRUG INTERACTION85 reports
BRADYCARDIA80 reports
DEPRESSION77 reports
ANAPHYLACTIC SHOCK67 reports
RESPIRATORY FAILURE66 reports
DRUG ABUSE64 reports
RENAL FAILURE ACUTE63 reports
SEPSIS58 reports
OFF LABEL USE55 reports
TOXICITY TO VARIOUS AGENTS55 reports
TACHYCARDIA54 reports
ATRIAL FIBRILLATION52 reports
ACUTE KIDNEY INJURY51 reports
COMA50 reports
SEROTONIN SYNDROME48 reports
RHABDOMYOLYSIS46 reports
CEREBROVASCULAR ACCIDENT45 reports
DYSPNOEA43 reports
PYREXIA43 reports
SHOCK43 reports
AGITATION40 reports
METABOLIC ACIDOSIS40 reports
HYPERTENSION39 reports
SEPTIC SHOCK39 reports
PNEUMONIA38 reports
VENTRICULAR FIBRILLATION37 reports
ANAESTHETIC COMPLICATION NEUROLOGICAL36 reports
HYPOXIA36 reports
ANAPHYLACTIC REACTION35 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME35 reports
MYOCARDIAL INFARCTION34 reports
HYPERTHERMIA MALIGNANT33 reports
PULMONARY OEDEMA32 reports
CARDIO RESPIRATORY ARREST31 reports
CONDITION AGGRAVATED31 reports
HYPERKALAEMIA30 reports
OVERDOSE29 reports
PRODUCT USE IN UNAPPROVED INDICATION29 reports
SEIZURE29 reports
ANAEMIA28 reports
MYOCLONUS28 reports
OXYGEN SATURATION DECREASED28 reports
VENTRICULAR TACHYCARDIA28 reports
VOMITING28 reports
BLOOD CREATININE INCREASED27 reports
BLOOD PRESSURE DECREASED27 reports
NAUSEA26 reports
ACUTE RESPIRATORY FAILURE25 reports
LOSS OF CONSCIOUSNESS25 reports
POST PROCEDURAL COMPLICATION25 reports
GENERALISED TONIC CLONIC SEIZURE24 reports
MUSCLE RIGIDITY24 reports
CARDIOGENIC SHOCK23 reports
DIABETES INSIPIDUS23 reports
INTENTIONAL OVERDOSE23 reports
RESPIRATORY DEPRESSION23 reports
ELECTROCARDIOGRAM QT PROLONGED22 reports
RESPIRATORY DISTRESS22 reports
THROMBOCYTOPENIA22 reports
CARDIAC FAILURE CONGESTIVE21 reports
METHAEMOGLOBINAEMIA21 reports
CONFUSIONAL STATE20 reports
ENCEPHALOPATHY20 reports
ADRENAL INSUFFICIENCY19 reports
BRONCHOSPASM19 reports
CARDIAC FAILURE19 reports
DRUG EXPOSURE DURING PREGNANCY19 reports
PLEURAL EFFUSION19 reports
APNOEA18 reports
COMPLETED SUICIDE18 reports
EJECTION FRACTION DECREASED18 reports
FATIGUE18 reports
FOETAL EXPOSURE DURING PREGNANCY18 reports
HAEMODYNAMIC INSTABILITY18 reports
HEART RATE DECREASED18 reports
PULSELESS ELECTRICAL ACTIVITY18 reports
CONVULSION17 reports
DIZZINESS17 reports
PHAEOCHROMOCYTOMA CRISIS17 reports
SOMNOLENCE17 reports
UNRESPONSIVE TO STIMULI17 reports
ABDOMINAL PAIN16 reports
ASTHENIA16 reports
ERYTHEMA16 reports

Report Outcomes

Out of 2,107 classified reports for ETOMIDATE:

Serious 91.6%Non-Serious 8.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1,020 (55.3%)
Female797 (43.2%)
Unknown26 (1.4%)

Reports by Age

Age 6061 reports
Age 5551 reports
Age 5845 reports
Age 6644 reports
Age 5941 reports
Age 6540 reports
Age 6838 reports
Age 6937 reports
Age 7237 reports
Age 5335 reports
Age 4734 reports
Age 7133 reports
Age 6131 reports
Age 7431 reports
Age 5429 reports
Age 6329 reports
Age 7029 reports
Age 4928 reports
Age 5728 reports
Age 6428 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ETOMIDATE?

This profile reflects 5,192 FDA FAERS reports that mention ETOMIDATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ETOMIDATE?

Frequently reported terms in FAERS include RENAL FAILURE, PAIN, INJURY, ANXIETY, UNEVALUABLE EVENT, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ETOMIDATE?

Labeling and FAERS entries often list Hospira, Inc. in connection with ETOMIDATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.